CoChat

Angiotensin receptor blockers improve survival outcomes after radiofrequency ablation in hepatocarcinoma patients

Facciorusso, Antonio, Del Prete, Valentina, Crucinio, Nicola, Muscatiello, Nicola, Carr, Brian I, Di Leo, Alfredo, Barone, Michele · 2015 · Journal of Gastroenterology and Hepatology
Cited by 75

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Background and Aim: Inhibition of angiotensin II synthesis seems to decrease hepatocellular carcinoma recurrence after radical therapies; however, data on the adjuvant role of angiotensin II receptor 1 blockers (sartans) are still lacking. The aim of the study was to evaluate whether sartans delay time to recurrence and prolong overall survival in hepatocellular carcinoma patients after radiofrequency ablation. Methods: Data on 153 patients were reviewed. The study population was classified into three groups: 73 (47.8%) patients who received neither angiotensin‐converting enzyme inhibitors nor sartans (group 1), 49 (32%) patients treated with angiotensin‐converting enzyme inhibitors (group 2), and 31 (20.2%) patients treated with sartans (group 3). Survival outcomes were analysed by means of K aplan–M eier analysis and compared with log–rank test. Results: In the whole study population, 85.6% of patients were in C hild–P ugh A class and 89.6% in B arcelona C linic L iver C ancer A stage. Median maximum tumor diameter was 30 mm (10–40) and alpha fetoprotein was 25 (1.1–2100) UI/mL. No differences in baseline characteristics among the three groups were reported. Median overall survival was 48 months (95% confidence interval: 31–58) in group 1, 72 months (49–89) in group 2, and 84 months (58–92) in group 3 (P = 0.02). Median time to recurrence was 26 (15–42), 44 (33–72), and 69 (44–74) months in the three groups, respectively (P = 0.02). Sartan therapy was a significant predictor of longer overall survival and delayed time to recurrence on multivariate analysis. Conclusion: Sartans significantly improved overall survival and time to recurrence after radiofrequency ablation in hepatocellular carcinoma patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jgh.12988

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 75

Metadata

Authors
Facciorusso, A., Del Prete, V., Crucinio, N., Muscatiello, N., Carr, B. I., Di Leo, A., & Barone, M.
Venue
Journal of Gastroenterology and Hepatology
Publisher
Wiley
Published
2015-10-12
Volume
30
Issue
11
Pages
1643-1650
ISSN
  • 0815-9319 (ISSN-L)
  • 1440-1746
OpenAlex
W2156901310
Cited by
75
References
3
FWCI
3.07
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Angiotensin receptor blockers improve survival outcomes after radiofrequency ablation in hepatocarcinoma patients. https://app.cochat.ai/papers/10.1111/jgh.12988
The paper
Facciorusso, A., Del Prete, V., Crucinio, N., Muscatiello, N., Carr, B. I., Di Leo, A., & Barone, M. (2015). Angiotensin receptor blockers improve survival outcomes after radiofrequency ablation in hepatocarcinoma patients. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.12988

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.